Brivudine
File:Brivudine - Brivudin.svg | |
Systematic (IUPAC) name | |
---|---|
5-[(E)-2-bromoethenyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Pregnancy category |
|
Routes of administration |
oral |
Pharmacokinetic data | |
Bioavailability | 30% |
Biological half-life | 16 hours |
Excretion | mainly renal |
Identifiers | |
CAS Number | 69304-47-8 |
ATC code | J05AB15 (WHO) |
PubChem | CID: 446727 |
ChemSpider | 394011 |
UNII | 2M3055079H |
ChEMBL | CHEMBL31634 |
Chemical data | |
Formula | C11H13BrN2O5 |
Molecular mass | 333.135 g/mol |
|
|
|
|
(what is this?) (verify) |
Brivudine is an antiviral drug used in the treatment of herpes zoster.
Contents
History
Brivudine is a similar drug to acyclovir.[clarification needed] The compound was first synthesized by scientists at the University of Birmingham in the UK in the 1970s. It was shown to be a potent inhibitor of the herpes simplex virus type 1 (HSV-1) as well as the varicella zoster virus (VZV) by Erik De Clercq at the Rega Institute for Medical Research in Belgium in 1979. In the 1980s the drug became commercially available in East Germany, where it was marketed as Helpin by a pharmaceutical company called Berlin-Chemie.
Approvals
Brivudine is approved for use in Germany and other European countries including Italy.
Mechanism of Action
Brivudine is an analogue of the nucleoside thymidine. The drug works because it is able to be incorporated into the viral DNA, but then blocks the action of DNA polymerases, thus inhibiting viral replication. The active compound is the 5'-triphosphate of BVDU, which is formed in subsequent phosphorylations by viral thymidine kinase and presumably by nucleoside diphosphate kinase.
Research
A Cochrane Systematic Review examined the effectiveness of multiple antiviral drugs in the treatment of herpes simplex virus epithelial keratitis. Brivudine was found to be significantly more effective than idoxuridine in increasing the number of successfully healed eyes of participants.[1]
The drug's name
Brivudine derives from the drug's chemical name of bromovinyldeoxyuridine or BVDU for short. The drug's full chemical description is (E)-5-(2-bromovinyl)-2-deoxyuridine. It is also sold as Bridic, Brivir (Greece), Brivox, Brivudin, Helpin, Zerpex, Zonavir and Zostex (Germany).
Suppliers
Brivudine main supplier is Berlin-Chemie, now part of Italy's Menarini Group. The drug is approved for sale in Austria, Belgium, Germany, Greece, Italy, Luxembourg, Portugal and Spain. In Central America is provided Menarini Centro America and Wyeth.
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Wikipedia articles needing clarification from July 2009
- Nucleosides
- Pyrimidinediones
- Organobromides
- Anti-herpes virus drugs